Sequence variants of IDE are associated with the extent of β-amyloid deposition in the Alzheimer's disease brain

Abraham, 2001, Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease, Hum Genet, 109, 646, 10.1007/s00439-001-0614-1 Alafuzoff, 1987, Histopathological criteria for progressive dementia disorders: clinical–pathological correlation and classification by multivariate data analysis, Acta Neuropathol, 74, 209, 10.1007/BF00688184 Bertram, 2000, Evidence for genetic linkage of Alzheimer's disease to chromosome 10q, Science, 290, 2302, 10.1126/science.290.5500.2302 Boussaha, 2002, Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease, Neurosci Lett, 329, 121, 10.1016/S0304-3940(02)00586-4 Campion, 1999, Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum, Am J Hum Genet., 65, 664, 10.1086/302553 Chalmers, 2003, APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein, Neuropathol Appl Neurobiol, 29, 231, 10.1046/j.1365-2990.2003.00457.x Eckman, 2001, Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme, J Biol Chem, 276, 24540, 10.1074/jbc.M007579200 Edbauer, 2002, Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD), J Biol Chem, 277, 13389, 10.1074/jbc.M111571200 Ertekin-Taner, 2000, Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees, Science, 290, 2303, 10.1126/science.290.5500.2303 Farris, 2003, Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo, Proc Natl Acad Sci USA, 100, 4162, 10.1073/pnas.0230450100 Finckh, 2000, Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease, Arch Neurol, 57, 1579, 10.1001/archneur.57.11.1579 Fratiglioni, 1991, Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education, Neurology, 41, 1886, 10.1212/WNL.41.12.1886 Goate, 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, 349, 704, 10.1038/349704a0 Hardy, 1997, Amyloid, the presenilins and Alzheimer's disease, Trends Neurosci, 20, 154, 10.1016/S0166-2236(96)01030-2 Hill, 1974, Estimation of linkage disequilibrium in randomly mating populations, Heredity, 33, 229, 10.1038/hdy.1974.89 Hu, 2001, Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity, J Biol Chem, 276, 47863, 10.1074/jbc.M104068200 Iwata, 2000, Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition, Nat Med, 6, 143, 10.1038/72237 Johnson, 2001, Haplotype tagging for the identification of common disease genes, Nat Genet, 29, 233, 10.1038/ng1001-233 Johnson-Wood, 1997, Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease, Proc Natl Acad Sci USA, 94, 1550, 10.1073/pnas.94.4.1550 Kuroshkin, 1994, Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme, FEBS Lett, 345, 33, 10.1016/0014-5793(94)00387-4 Li, 2002, Age at onset in two common neurodegenerative diseases is genetically controlled, Am J Human Genet, 70, 985, 10.1086/339815 Miller, 2003, Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo, Proc Natl Acad Sci USA, 100, 6221, 10.1073/pnas.1031520100 Myers, 2000, Susceptibility locus for Alzheimer's disease on chromosome 10, Science, 290, 2304, 10.1126/science.290.5500.2304 Prince, 2003, Genetic variation in a haplotype block spanning IDE influences Alzheimer disease, Hum Mut, 22, 363, 10.1002/humu.10282 Prince, 2001, Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation, Genome Res, 11, 152, 10.1101/gr.150201 Qiu, 1998, Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation, J Biol Chem, 273, 32730, 10.1074/jbc.273.49.32730 Rogaev, 1995, Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene, Nature, 376, 775, 10.1038/376775a0 Selkoe, 2001, Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein, J Alzheimers Dis, 3, 75, 10.3233/JAD-2001-3111 Selkoe, 2000, The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins, Neurol Clin, 18, 903, 10.1016/S0733-8619(05)70232-2 Sherrington, 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, 375, 754, 10.1038/375754a0 Shinkai, 1997, Amyloid beta-protein deposition in the leptomeninges and cerebral cortex, Ann Neurol, 42, 899, 10.1002/ana.410420612 Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci USA, 90, 1977, 10.1073/pnas.90.5.1977 Tanzi, 2001, New frontiers in Alzheimer's disease genetics, Neuron, 32, 181, 10.1016/S0896-6273(01)00476-7 Tombaugh, 1992, The mini-mental state examination: a comprehensive review, J Am Geriatr Soc, 40, 922, 10.1111/j.1532-5415.1992.tb01992.x Ertekin-Taner, 2004, Genetic variants in a haplotype block spanning IDE are significantly associated with plasma ab42 levels and risk for Alzheimer disease, Hum Mut, 23, 334, 10.1002/humu.20016